Login / Signup

Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis.

Florence R WilsonMegan E CoombesChristine Brezden-MasleyMariya YurchenkoQuinlan WylieReuben DoumaAbhishek VaruBrian HuttonBecky SkidmoreChris Cameron
Published in: Systematic reviews (2018)
PROSPERO CRD42017055763.
Keyphrases
  • early breast cancer
  • systematic review
  • meta analyses
  • epidermal growth factor receptor
  • metastatic breast cancer
  • tyrosine kinase